English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Antimicrobial resistance (AMR) is an increasing threat to public health. A key factor that accelerates AMR is the misuse and overuse of antimicrobials. Access to antibiotics without prescription, self-medication, as well as lack of rapid and sufficient diagnostic tests are among the most important drivers of AMR. This article will focus on legal and regulatory interventions to avoid the misuse and overuse of antimicrobials taking into account the recent Commission proposal to review the EU pharmaceutical legislation (Directive 2001/83 and Regulation (EC) 726/2004), which was published on 26 April 2023.

european health and pharmaceutical law review

Preserving our Defences – Prudent and Appropriate Use of Antimicrobials Legal and Regulatory Interventions on Antimicrobial Resistance in the Recent Commission Proposal to Review the EU Pharmaceutical Legislation